No abstract available
MeSH terms
-
Biomarkers, Tumor / blood*
-
Carcinoma / blood
-
Carcinoma / diagnosis*
-
Carcinoma / epidemiology
-
Carcinoma / pathology
-
Cost-Benefit Analysis
-
Diagnostic Tests, Routine
-
Disease Progression
-
Europe / epidemiology
-
Forecasting
-
Humans
-
Male
-
Mass Screening* / economics
-
Mass Screening* / psychology
-
Mortality / trends
-
Predictive Value of Tests
-
Prostate-Specific Antigen / blood*
-
Prostatic Neoplasms / blood
-
Prostatic Neoplasms / diagnosis*
-
Prostatic Neoplasms / epidemiology
-
Prostatic Neoplasms / pathology
-
Risk Factors
Substances
-
Biomarkers, Tumor
-
Prostate-Specific Antigen